Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Atreca Inc BCEL

Alternate Symbol(s):  COLUF

Atreca, Inc. is a clinical-stage biopharmaceutical company. The Company is discovering and developing antibody-based therapeutics to treat a range of solid tumor types. Its most advanced product candidate, ATRC-101, is a monoclonal antibody with a mechanism of action and target derived from an antibody identified using its discovery platform. ATRC-101 reacts in vitro with a majority of human... see more

PINL:BCEL - Post Discussion

Atreca Inc > Atreca 12 month Price Target between 10$ & 25$
View:
Post by longon01 on Mar 05, 2023 7:47am

Atreca 12 month Price Target between 10$ & 25$

Are the 3 stock price forecasters credible?
When the stock is at the 1.40$ mark.
If so, why are investors not buying way more of this company?
Seems odd
All feedback is welcome. 
Thank you
 
Be the first to comment on this post